Detalles de la búsqueda
1.
A study protocol outlining the development and evaluation of a training program for frontline managers on leading well-being and the psychosocial work environment in Danish hospital settings - a cluster randomized waitlist controlled trial.
BMC Public Health
; 23(1): 848, 2023 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37165331
2.
Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression.
Acta Psychiatr Scand
; 133(2): 154-164, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26138003
3.
Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium.
Clin Exp Immunol
; 155(2): 257-65, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19137636
4.
Genetic alterations of CCND1 and EMSY in breast cancers.
Histopathology
; 52(6): 698-705, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18393977
5.
A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells.
Oncogene
; 34(32): 4199-210, 2015 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25362855
6.
Vitronectin and substitution of a beta-strand 5A lysine residue potentiate activity-neutralization of PA inhibitor-1 by monoclonal antibodies against alpha-helix F.
Thromb Haemost
; 83(5): 742-51, 2000 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-10823273
7.
Proteinases in bone resorption: obvious and less obvious roles.
Clin Chim Acta
; 291(2): 223-34, 2000 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-10675725
8.
Frequent amplifications and deletions of G1/S-phase transition genes, CCND1 and MYC in early breast cancers: a potential role in G1/S escape.
Cancer Biomark
; 5(1): 41-9, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19242061
9.
Observer variation in immunohistochemical analysis of protein expression, time for a change?
Histopathology
; 48(7): 787-94, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16722926
10.
Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease.
Gut
; 53(5): 701-9, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15082589
11.
Tumour necrosis factor-alpha converting enzyme (TACE) activity in human colonic epithelial cells.
Clin Exp Immunol
; 135(1): 146-53, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14678276
12.
Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease.
Gut
; 51(1): 37-43, 2002 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12077089
13.
Engineering of conformations of plasminogen activator inhibitor-1. A crucial role of beta-strand 5A residues in the transition of active form to latent and substrate forms.
Eur J Biochem
; 263(2): 577-86, 1999 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-10406969
14.
Kinetic analysis of integrin-dependent cell adhesion on vitronectin--the inhibitory potential of plasminogen activator inhibitor-1 and RGD peptides.
Eur J Biochem
; 253(3): 669-74, 1998 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-9654064
15.
Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
Exp Cell Res
; 232(2): 420-9, 1997 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-9168821
Resultados
1 -
15
de 15
1
Próxima >
>>